Clinical trial

A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

NCT06979375

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention CDR132L Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-06-30

PhasePHASE2

Conditions

Heart Failureverified · MONDO: heart failure

Interventions

CDR132LDRUG

PlaceboDRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

SeoulSouth Korea4 LondonUnited Kingdom4 BerlinGermany3 PragueCzechia3 MadridSpain2 KrakowPoland2 BarcelonaSpain1 WarsawPoland1 ValenciaSpain1 SevilleSpain1 AmsterdamNetherlands1 MálagaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06979375 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.